Google enhances its Jules AI coding assistant with new command line tools and API support, while Nvidia introduces a revolutionary 4-bit training format that cuts AI training costs, and MIT researchers use generative AI to dramatically accelerate antibiotic discovery from years to much shorter timeframes.
AstraZeneca strikes a massive $555 million partnership with Algen Biotechnologies, combining cutting-edge AI platform 'AlgenBrain' with CRISPR gene technology to revolutionize drug discovery for chronic inflammatory diseases and unlock next-generation immunology therapies.
MIT and McMaster University researchers use AI to discover enterololin, a revolutionary narrow-spectrum antibiotic that targets harmful gut bacteria causing Crohn's disease while preserving beneficial microbes, showing promising results in mouse studies and advancing toward human trials.
RNA structure prediction remains far behind protein prediction as AlphaFold3 struggles with RNA's extreme flexibility, with only 7,759 RNA structures mapped versus 216,212 proteins, though most RNA therapeutics like mRNA vaccines rely on secondary structure which scientists can now predict with high accuracy.
Eli Lilly unveils TuneLab, an AI-driven drug discovery platform backed by a $1 billion research investment, offering biotech companies access to AI models built on Lilly's extensive drug data and joining Lilly Catalyze360's offerings for biotech partners.
Researchers harness AI to uncover abaucin, a groundbreaking antibiotic disrupting lipoprotein trafficking, offering a potent weapon against drug-resistant Acinetobacter baumannii bacteria, sparking hope for treating stubborn wound infections.
Generative AI pioneers novel antibiotics that disrupt bacterial cell membranes, offering potential solutions against drug-resistant gonorrhea, MRSA, and other superbugs in the ongoing battle against antimicrobial resistance.
Groundbreaking AI models generate novel antibiotics NG1 and DN1 that effectively combat multidrug-resistant superbugs like gonorrhea and MRSA, iteratively building and optimizing molecular structures for potency and safety.
Federal funding cuts leave US biomedical research in crisis as UMass Chan Medical School receives only $2 million in grants versus the typical $25-30 million, while private investors focus on short-term commercial projects rather than basic science, creating a devastating $23 million funding gap.
Oracle unveils MCP server enabling AI agents to autonomously query and reason over enterprise data in Oracle Databases, boosting productivity and data utilization across sectors like pharma, healthcare, and finance.